In situ-transition nanozyme triggered by tumor microenvironment boosts synergistic cancer radio-/chemotherapy through disrupting redox homeostasis.
In situ-transition nanozyme triggered by tumor microenvironment boosts synergistic cancer radio-/chemotherapy through disrupting redox homeostasis.
复制标题
DOI:
10.1016/j.biomaterials.2022.121620
复制
发表时间:
2022-06
期刊:
影响因子:
14
通讯作者:
Zhongwen Yuan;Xinxin Liu;Jiabao Ling;Guanning Huang;Jiarun Huang;Xueqiong Zhu;Lizhen He;Tianfeng Che
中科院分区:
文献类型:
--
作者:
Zhongwen Yuan;Xinxin Liu;Jiabao Ling;Guanning Huang;Jiarun Huang;Xueqiong Zhu;Lizhen He;Tianfeng Che
Disrupting redox homeostasis in the tumor microenvironment (TME), like excessive H2O2, glutathione (GSH) and weak acidity, has been proved as an effective tumor therapeutic strategy. Herein, we constructed a TME-responsive nanozyme, DOX@HMSN/Mn3O4(R), with reversible Mn3+/Mn2+transitionin situtriggered by TME to perturb the intrinsic redox homeostasis and catalyze reactive oxygen species (ROS) overproduction. In addition, this nanozyme could react with excess GSH in TME to produce GSSG, resulting in the consumption of reducing agents to suppress ROS clearance. Density functional theory calculations further confirmed that the nanozyme mainly exhibited the oxidase-like activity to catalyze the formation of hydroxyl radicals from O2, thus strengthening the oxidation environment in the TME. Combined with radiotherapy, the high-energy X-ray could excite the outer-layer electrons in the nanozyme, forming photoelectrons that participate in the oxidase-like enzymatic reaction, thus intensifying ROS accumulation and amplifying the radio-/chemotherapeutic efficacy.